IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
86 hedge funds and large institutions have $220M invested in IGM Biosciences in 2024 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 21 increasing their positions, 23 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.63% more ownership
Funds ownership: 66.9% → 68.54% (+1.6%)
9% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 23
Holders
86
Holding in Top 10
–
Calls
$107K
Puts
$49K
Top Buyers
| 1 | +$6.06M | |
| 2 | +$4.32M | |
| 3 | +$3.83M | |
| 4 |
Goldman Sachs
New York
|
+$2.3M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$974K |
Top Sellers
| 1 | -$3.68M | |
| 2 | -$3.32M | |
| 3 | -$1.91M | |
| 4 |
EAM
Exome Asset Management
New York
|
-$1.13M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.03M |